Atlantic Exchange

Atlantic Exchange with Marc Andreessen

May 19, 2014
Washington, DC

On Monday, May 19, venture capitalist and entrepreneur Marc Andreessen joined The Atlantic at DC startup incubator 1776 for a conversation on Bitcoin, Silicon Valley, and the next wave of the internet. In a one-on-one interview with Editor-in-Chief James Bennet, Andreessen shared his thoughts on a wide range of topics, from his views on the future of education to the American surveillance state.

Presented by

Atlantic Live

Also in This Series

  • Technology

    Atlantic Exchange featuring Devin Wenig

    Our series of intimate interviews with disruptive innovators and consequential political, community and business leaders continued with a discussion between eBay Chief Executive Officer and President Devin Wenig and Steve Clemons.

  • Atlantic Exchange featuring
    John Donvan and Caren Zucker

    Our series of intimate interviews with prominent leaders continued as The Atlantic’s James Bennet hosted a conversation with John Donvan, Correspondent for ABC News' "Nightline," and Caren Zucker, Producer for ABC News and Co-Writer of the PBS series “Autism Now.”

  • Politics

    Atlantic Exchange:
    The State of the Union and the Chance for Criminal Justice Reform

    Our series of interviews with disruptive innovators and consequential political, community and business leaders continued with a discussion featuring Bob Goodlatte regarding the effort for bipartisan criminal justice reform.

Upcoming Events

  • Education

    Education Summit 2016

    The Atlantic will gather educators, policymakers, parents and students to illuminate the most pressing debates in the education world today.

  • City Makers Summit

    The Atlantic will host a half-day forum in Chicago to explore how philanthropy and corporate responsibility are driving growth and opportunity in the Windy City.

  • Health Care

    The Search for Answers:
    Fighting Rare Cancers

    The Atlantic will convene top cancer researchers and doctors, alongside patients and survivors, to discuss the battle against rare cancer.